The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1326
November 30, 2009
View Complete Issue         Table of Contents 2019 
Issue 1326
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Colchicine and Other Drugs for Gout
November 30, 2009 (Issue: 1326)
Until the recent introduction of febuxostat (Uloric), no new drugs had been marketed for treatment of gout in the past 40 years. Colchicine, which has been available for decades as an unapproved drug, has now been approved by the FDA (Colcrys) for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1326
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.